ArticleCancers2021

Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome.

Sabine Seidel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.